Skip to main content
Top
Published in: International Journal of Hematology 1/2017

01-07-2017 | Case Report

Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)

Authors: Takuya Shimizu, Kazuo Hatanaka, Hitomi Kaneko, Toshihide Shimada, Kazunori Imada

Published in: International Journal of Hematology | Issue 1/2017

Login to get access

Abstract

A 49-year-old female from China was referred to our hospital after endocervical polypectomy. Twenty years before admission, after the birth of her first child, an intrauterine device (IUD) had been inserted due to the one-child policy in China. She had noticed abnormal vaginal bleeding with a foul smell 3 years before admission. Then the IUD was removed and a polyp was found at the IUD contact site. Two months before admission, endocervical polypectomy was performed. Lymphoma was suspected by histological examination and she was referred to our hospital. Further examination confirmed the diagnosis of primary uterine diffuse large B-cell lymphoma (DLBCL). Subsequently, a combination of three cycles of R-CHOP regimen and involved-field radiation therapy was performed, followed by maintenance therapy with five cycles of rituximab. She has remained in complete remission for over 1 year. This case suggests that chronic inflammation induced by prolonged IUD insertion may contribute to the development of primary uterine lymphoma. To the best of our knowledge, this is the first reported case of DLBCL associated with prolonged IUD insertion.
Literature
1.
go back to reference Yun J, Kim SJ, Kim JA, Kong JH, Lee SH, Kim K, et al. Clinical features and treatment outcomes of non-Hodgkin’s lymphomas involving rare extranodal sites: a single-center experience. Acta Haematol. 2010;123:48–54.CrossRefPubMed Yun J, Kim SJ, Kim JA, Kong JH, Lee SH, Kim K, et al. Clinical features and treatment outcomes of non-Hodgkin’s lymphomas involving rare extranodal sites: a single-center experience. Acta Haematol. 2010;123:48–54.CrossRefPubMed
2.
go back to reference Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, de Jong D, Fayad LE, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol. 2014;32:114–20.CrossRefPubMed Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, de Jong D, Fayad LE, et al. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol. 2014;32:114–20.CrossRefPubMed
3.
go back to reference Gutman PD, Williams JP, Dveksler GS, Hoffmeister K, Cotelingam JD. T-cell-rich B-cell lymphoma and Epstein-Barr virus infection of the uterus in a postmenopausal patient with an intrauterine contraceptive device in place for over 20 years. Gynecol Oncol. 1998;68:288–92.CrossRefPubMed Gutman PD, Williams JP, Dveksler GS, Hoffmeister K, Cotelingam JD. T-cell-rich B-cell lymphoma and Epstein-Barr virus infection of the uterus in a postmenopausal patient with an intrauterine contraceptive device in place for over 20 years. Gynecol Oncol. 1998;68:288–92.CrossRefPubMed
4.
go back to reference Sun XF, Feng J, Liu W. Primary mesenteric follicular lymphoma associated with mesenteric migration of intrauterine device. Turk J Haematol. 2013;30:433–4.CrossRefPubMedPubMedCentral Sun XF, Feng J, Liu W. Primary mesenteric follicular lymphoma associated with mesenteric migration of intrauterine device. Turk J Haematol. 2013;30:433–4.CrossRefPubMedPubMedCentral
5.
go back to reference Castellsagué X, Diaz M, Vaccarella S, de Sanjosé S, Muñoz N, Herrero R, et al. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. Lancet Oncol. 2011;12:1023–31.CrossRefPubMed Castellsagué X, Diaz M, Vaccarella S, de Sanjosé S, Muñoz N, Herrero R, et al. Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. Lancet Oncol. 2011;12:1023–31.CrossRefPubMed
Metadata
Title
Primary uterine diffuse large B-cell lymphoma (DLBCL) in a patient with prolonged insertion of intrauterine device (IUD)
Authors
Takuya Shimizu
Kazuo Hatanaka
Hitomi Kaneko
Toshihide Shimada
Kazunori Imada
Publication date
01-07-2017
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 1/2017
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-017-2191-7

Other articles of this Issue 1/2017

International Journal of Hematology 1/2017 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine